Patients with type 1 diabetes (T1D) must continually decide how much insulin to inject before each meal to maintain an acceptable level of blood glucose. Recent research has worked on a solution for this burden: the artificial pancreas (AP), which is a closed-loop system combining a continuous glucose monitor (CGM) and an insulin pump with a decision-making algorithm. The goal of this thesis is ...